Abiopharma

🔍 Calabria Carlo (Director)

Company: Arqit Quantum Inc. (ARQQ)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 1,698 shares of Ordinary Shares (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 110,922.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,698 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,698.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 1,698 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-06 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Restricted Stock Units ("RSUs") convert into ARQQ ordinary shares on a one-for-one basis. The RSUs vested immediately on the date of grant.
• REMARKS: Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the issuer's securities are exempt from Sections 16(b) and 16(c) of the Act.